American Assets Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

American Assets Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.69M	Hold	7,000	–	–	0.1%	126
2026 Q1	$1.32M	Hold	7,000	–	–	0.09%	129
2025 Q4	$1.19M	Hold	7,000	–	–	0.08%	133
2025 Q3	$923K	Hold	7,000	–	–	0.07%	138
2025 Q2	$743K	Hold	7,000	–	–	0.06%	139
2025 Q1	$869K	Hold	7,000	–	–	0.08%	140
2024 Q4	$862K	Hold	7,000	–	–	0.07%	143
2024 Q3	$780K	Hold	7,000	–	–	0.07%	152
2024 Q2	$747K	Hold	7,000	–	–	0.07%	147
2024 Q1	$843K	Hold	7,000	–	–	0.08%	140
2023 Q4	$861K	Hold	7,000	–	–	0.09%	138
2023 Q3	$906K	Hold	7,000	–	–	0.1%	136
2023 Q2	$868K	Hold	7,000	–	–	0.1%	137
2023 Q1	$1.02M	Hold	7,000	–	–	0.12%	133
2022 Q4	$1.12M	Hold	7,000	–	–	0.13%	126
2022 Q3	$933K	Hold	7,000	–	–	0.12%	128
2022 Q2	$1.09M	Hold	7,000	–	–	0.14%	125
2022 Q1	$1.09M	Buy	+7,000	New	+$1.02M	0.12%	137

Other funds holding JAZZ

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

ACM

Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

American Assets Investment Management's JAZZ Position: Q2 2026 in Review

American Assets Investment Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 7,000 shares worth $1.69M. The position accounts for 0.1% of the portfolio, ranked #126.

American Assets Investment Management first reported a position in JAZZ in Q1 2022 and has held it in 18 quarters since. 259 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

American Assets Investment Management held 7,000 shares of Jazz Pharmaceuticals worth $1.69M as of Q2 2026.
American Assets Investment Management left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
Jazz Pharmaceuticals made up 0.1% of American Assets Investment Management's portfolio in Q2 2026, its #126 holding.
American Assets Investment Management first reported a position in Jazz Pharmaceuticals in Q1 2022 and has held it in 18 quarters since.
259 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on American Assets Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.